Open research questions in Acute Myocardial Infarction Research
497 gap statements mined from Acute Myocardial Infarction Research papers in our 7.9M-paper local library, which holds 2,537 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Acute Myocardial Infarction Research? See the ranked Medicine journals.
What the literature leaves open
The incidence of right ventricular involvement among patients with RCA-related STEMI is not well established. The relationship between right ventricular involvement and bleeding and mortality outcomes is not fully understood. The study aims to address this gap by analyzing data from a nationwide registry.
Impact of Right Ventricular Involvement on Bleeding and Mortality in Patients With Right Coronary Artery-Related Myocardial Infarction ― Insights From Nationwide Registry ― · 2026 · DOIThe gap is the lack of understanding of the long-term prognosis in STEMI patients with HFpEF. The gap is the limited knowledge on the prognostic impact of HFpEF on STEMI patients.
Long-Term Prognosis in Patients with ST-Elevation Myocardial Infarction Complicated by Heart Failure with Preserved Left Ventricular Ejection Fraction · 2025 · DOIThe current study aims to address the gap in identifying laboratory, clinical, and imaging indicators of distal coronary embolism. Prior studies have identified distal coronary embolism as a predictor of poor outcomes, but the current study seeks to identify specific biomarkers and indicators.
Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention · 2025 · DOIThe NIS also lacks information on the quality of care. The study focused on in-hospital outcomes due to the limitations of the NIS database, which does not provide post-discharge follow-up data. The CKM classification depends on ICD codes, which may not fully reflect the syndrome's complexity.
Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients · 2025 · DOIAdditional studies are needed to evaluate the optimal diagnosis and management of AMI in patients without traditional cardiovascular risk factors. Future research should focus on identifying specific mechanisms underlying AMI in this population, - Developing targeted strategies to improve their outcomes, - Better understanding the interplay between CKM severity, treatment strategies, and long-term prognosis.
Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients · 2025 · DOIHowever, up-to-date information on the incidence and prognostic impact of arrhythmias following this event is lacking.
Clinical Impact of Arrhythmias Detected by an Implantable Cardiac Monitoring Device With Real-Time Transmission Among Patients With Early Reduced Left Ventricular Ejection Fraction After ST-Segment Elevation Acute Myocardial Infarction · 2026 · DOIAlthough infusion of supersaturated oxygen (SSO 2) after primary percutaneous coronary intervention (PPCI) has been shown to reduce IS among patients with acute anterior ST-segment elevation myocardial infarction (STEMI), the cost-effectiveness of this approach remains unknown.
Cost-Effectiveness of Supersaturated Oxygen Delivery for Infarct Size Reduction in Patients With Anterior ST-Segment Elevation Myocardial Infarction · 2026 · DOIThe PI population remains vastly understudied in contemporary interventional cardiology practice.
An Evaluation of the Use of Fibrinolytic Therapy for Treatment of STEMI in Northern New England Over Two Decades · 2026 · DOIAdding Gal-3 to established risk scores yielded higher apparent discrimination and secondary exploratory reclassification metrics; however, the magnitude of these differences remains uncertain and may still be optimistic despite bootstrap correction.
Galectin-3–enhanced prognostic models for major adverse cardiovascular events in Vietnamese patients with acute coronary syndrome: A prospective cohort study · 2026 · DOIAlthough guidelines recommend invasive management for non–ST-segment–elevation myocardial infarction (NSTEMI), there is considerable variability in the application of these recommendations across different hospitals, reflecting a lack of standardized clinical pathways and highlighting ongoing uncertainty in real-world practice.
Hospital-Level Variability in NSTEMI Management: Findings From the NCDR Chest Pain-MI Registry · 2026 · DOIOxidative stress and ferroptosis are increasingly recognized as key contributors to the pathogenesis of ST-segment elevation myocardial infarction (STEMI), although the clinical relevance of circulating molecules linked to these processes remains insufficiently defined.
Circulating 4-Hydroxynonenal Is Associated with Clinical Severity in ST-Segment Elevation Myocardial Infarction · 2026 · DOICardiogenic shock (CS) elevates mortality rates among patients with acute myocardial infarction (AMI), yet there are insufficient data on trends in mortality.
Trends in Mortality Among Adults With Acute Myocardial Infarction With Cardiogenic Shock in the United States, 1999-2023 · 2025 · DOIPeriodontal disease is linked to increased cardiovascular morbidity, but its impact on outcomes in ST elevation myocardial infarction (STEMI) remains understudied.
A-2 | Associations between Periodontal Disease and Hospitalization Outcomes in ST Elevation Myocardial Infarction: Insights from the United States National Inpatient Sample · 2025 · DOITelemedicine has been conversely hypothesized to carry an excess of false-positive diagnoses; however, comparisons with a traditional diagnostic process at non-percutaneous coronary intervention capable (“Spoke”) hospitals are lacking.
Comparative performance of spoke centers versus telemedicine service in the emergency activation of ST elevation myocardial infarction network: Insights from the “detective” registry · 2025 · DOIWhile high sensitivity cardiac troponin (hs‐cTn) research has focused on HBEDs, its application in FSEDs remains unexplored.
Comparing Outcomes of a Rapid High‐Sensitivity Troponin Protocol Between Hospital‐Based and Freestanding Emergency Departments · 2025 · DOIRenal transplantation (RT) significantly improves quality of life & improves survival; however, reduction in CV mortality is understudied.
A-5 | Outcomes of ST Elevations Myocardial Infarction in Renal Transplant Recipients Compared to Patients without Kidney Disease · 2024 · DOIOutcomes of STEMI in the presence of Chronic total occlusion (CTO) of a secondary vessel are not well known.
A-8 | Propensity Matched In-Hospital Outcomes of Acute ST Elevation Myocardial Infarction in Patients with Simultaneous Chronic Total Occlusion · 2024 · DOIRecent studies show that patients without standard modifiable risk factors (SMuRF-less) have poorer outcomes in acute myocardial infarction (AMI).
OR6-6 | In-Hospital Outcomes of Post-Myocardial Infarction Complications In Patients Without Standard Modifiable Risk Factors: A Nationwide Analysis · 2024 · DOIOutdated derivation cohorts - Overfitting - Lack of generalizability - High inter-observer variability - Limited predictive ability for long-term…
Personalized Treatment of Patients with Coronary Artery Disease: The Value and Limitations of Predictive Models · 2025 · DOIDevelopment of more accurate and generalizable predictive models - Integration of artificial intelligence and machine learning models into clinical practice - Investigation of ethical issues, such as equity in model application…
Personalized Treatment of Patients with Coronary Artery Disease: The Value and Limitations of Predictive Models · 2025 · DOIEmerging technologies, particularly artificial intelligence for ECG interpretation, offer promise for further time reduction, - Evaluation of the effectiveness of public awareness campaigns and regionalized STEMI…
The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction · 2025 · DOIPersistent disparities based on geography, presentation timing, sex, race, and age remain problematic, - The need for targeted interventions to reduce total ischemic…
The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction · 2025 · DOIRetrospective study design, - Limited to patients with isolated LAD artery disease, - No comparison to conventional sternotomy-based CABG, - Potential for selection bias in patient…
Sex-Based Comparative Analysis of Outcomes Following Minimally Invasive Direct Coronary Artery Bypass: A 20-Year Study · 2025 · DOIInvestigation of sex-specific differences in MIDCAB outcomes in larger, more diverse populations, - Comparison of MIDCAB to conventional CABG in terms of long-term outcomes and sex-specific differences, - Examination of the impact of clinical risk factors on prognosis in MIDCAB…
Sex-Based Comparative Analysis of Outcomes Following Minimally Invasive Direct Coronary Artery Bypass: A 20-Year Study · 2025 · DOIFurther studies are needed to confirm the findings and explore the relationship between DHEA-S and distal coronary embolism, - Research should investigate the potential therapeutic applications of DHEA-S in the management of ACS, - Studies should examine the relationship between other biomarkers and distal coronary…
Markers in Acute Coronary Syndrome: Distal Coronary Embolism at Percutaneous Coronary Intervention · 2025 · DOI
Most-cited papers in Acute Myocardial Infarction Research
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction · New England Journal of Medicine · 1992 · 4,557 citations
- Optimal Medical Therapy with or without PCI for Stable Coronary Disease · New England Journal of Medicine · 2007 · 3,823 citations
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials · The Lancet · 2003 · 3,351 citations
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction · New England Journal of Medicine · 1993 · 3,217 citations
- The Thrombolysis in Myocardial Infarction (TIMI) Trial · New England Journal of Medicine · 1985 · 2,965 citations
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction · New England Journal of Medicine · 2019 · 2,906 citations
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock · New England Journal of Medicine · 1999 · 2,624 citations
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI · JAMA · 2000 · 2,613 citations
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock · New England Journal of Medicine · 2012 · 2,554 citations
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction · The Lancet · 1998 · 2,461 citations
Most recent work
- Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study · Clinical Chemistry · 2026
- High-Sensitivity Cardiac Troponin T-gen6 Assay in Suspected Myocardial Infarction · Journal of the American College of Cardiology · 2026
- Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay · JAMA Cardiology · 2026
- Slow flow and no reflow after percutaneous coronary intervention · EuroIntervention · 2026
- A new definition of MINOCA: from infarction to injury · European Heart Journal · 2026
- Intracoronary Vasoactive Therapy for No-Reflow During Primary PCI · JACC Advances · 2026
- Discontinuation of Beta-Blocker Therapy after Myocardial Infarction · New England Journal of Medicine · 2026
- Accelerated Diagnostic Pathways for Suspected Acute Coronary Syndrome in Practice · Journal of the American College of Cardiology · 2026
- Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis · Journal of the American College of Cardiology · 2026
- Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040 · JACC Asia · 2026
Find a gap in your own Acute Myocardial Infarction Research sub-topic
This page shows what the Acute Myocardial Infarction Research literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →